Conference Full Schedule
This event has been prior approved by the American Association of Nurse Anesthesiology for 14.00 Class A CE credits; Code Number 1046397; Expiration Date 4/12/2026. The AANA designates this program as meeting the criteria for up to 5.25 CE credits in Pharmacology and Therapeutics. The AANA designates this program as meeting the criteria for up to 1.00 CE credits in Pain Management.
Saturday, April 11, 2026
| 7:00 -7:30 am |
Registration and Breakfast |
| 7:30 a.m. |
Opening Statements and Welcome
Vic Tackett, APRNA, CRNA - OANA President
|
| 7:30-9:30 a.m. |
*Let's Party! Old and New Psychoactive Substances - Scott Herring (*2)
- Identify examples of old and new psychoactive substances.
- Explain how to test for and identify the use of psychoactive
- Substances.
- Describe the anesthetic implications of psychoactive substances.
|
| 9:30-10:00 a.m. |
Break with Exhibitors
|
| 10:00-11:00 a.m. |
*Alpha-Gall Syndrome Identification and Risk Management in the Perioperative Setting - Shannon Noffsinger, DNAP, CRNA (*.5)
- Understand Alpha-Gal Syndrome (AGS) transmission, incidence, risk factors, and pathogenicity.
- Understand common triggers for AGS in the perioperative environment.
- Understand methods for identifying undiagnosed AGS in patients and be able to develop a safe anesthetic plan for this patient population through a discussion of current evidence and recent case studies.
|
| 11:00 a.m..- Noon |
AANA Update - Gregory Collins, DNP, CRNA
- Describe trends in AANA membership demographics, education, employment, and public relations.
- List the factors driving our national scope of activities.
- Explain the initiatives regarding CRNA Wellness, PAC, and research.
|
|
Noon - 1:00 p.m.
1:00 - 2:00 p.m.
|
Lunch with Exhibitors
OANA Update - Vic Tackett, APRNA, CRNA
- Explain the inception of the OANA and name the founders.
- State and describe three pivotal moments in OANA history.
|
| 2:00 - 3:00 p.m. |
GLP-1 Agonists: The case for POCUS Assessment of the Gastric Antrum - Gregory Collins, DNP, CRNA
- Illustrate the ubiquity and anesthetic implications of GLP-1 agonist therapy.
- Develop clinical decision-making tools regarding gastric contents.
- Demonstrate ultrasound recognition and assessment of gastric antrum.
|
| 3:00-4:00 p.m. |
*Medical Cannabis Science and Therapeutics - Mary Scott-Herring, DNP, MS, CRNA (*1)
- Identify the types and formulations of cannabis.
- Articulate the effects of cannabis and how to manage them.
- Describe indications for cannabis treatment.
|
|
4:00-5:00 p.m.
|
Student Presentations
|
|
|
|
|
Sunday, April 12, 2026
| 7:00-7:30 am |
Welcome Back! Registration and Breakfast |
| 7:30-8:30 a.m. |
*CRNAs as First Responders - Mary Scott-Herring, DNP, MS, CRNA (*.25)
- Explain the EMS system
- Compare skills sets/medication/equipment used
- Analyze the types of patients treated
:
|
| 8:30-9:30 a.m. |
*Neuraxial Dexmedetomidine: Help or Hype? - Gregory Collins, DNP, CRNA (*1)
- Review the pharmacology of dexmedetomidine.
- Consider the evidence regarding the safety and efficacy of neuraxial dexmedetomidine.
- Propose avenues to incorporate neuraxial dexmedetomidine into current practice.
|
| 9:30-10:00 a.m. |
Break w/ Exhibitors |
| 10:00 a.m.-11:00 a.m. |
Perioperative Uses for TXA - Shannon Noffsinger, DNAP, CRNA
- Understand the mechanism of action, pharmacology, and safety profile of TXA.in perioperative patient care.
- Analyze current evidence of TXA administration across surgical specialties, identifying uses backed by substantive data and areas where data remains equivocal.
- Integrate TXA administration into perioperative patient blood management strategies based on current evidence while tailored to surgical context and patient-specific factors.
|
|
11:00 a.m.-1:00 p.m.
|
Student Presentations
|
| 1:00 p.m. |
Closing Remarks
Vic Tackett, CRNA, OANA President
|
| |
Posters - 2 Hours of Instruction
Twenty poster sessions will be presented Saturday, 7:00 a.m.-Sunday, 10:00 a.m.
|
|
|
|
*Indicates Pharmacology credit
|
